Company Analysis

Covista Inc. (CVSA)

NYSE: CVSA · Services-Educational Services · Chicago, IL · filing with the SEC since 1995
Grade6.7
◀ Past 6.9● Present 6.7▶ Future 6.5

Filings

310 filings since 2017 beside 656 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-Q Quarterly report for the quarter ending Dec 31, 2026Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by Feb 9, 2027
10-K Annual report for the fiscal year ending Jun 30, 2027Large accelerated filers have 60 days after the fiscal year ends. by Aug 29, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 29 days after the quarter ended. The proxy statement was last filed Oct 2, 2026.

Filings a yearinsider forms included
83821199093958676
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 4 times in the last 36 months, the newest Jul 28, 2026.SEC letters: 3 in the last 36 months, the newest Mar 4, 2025.
Insider forms 656

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 13, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 5, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 4, 2026 S-8 Employee stock plan registration
Oct 29, 2026 10-Q Quarterly report Sep 30, 2026
Oct 29, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 14, 2026 DEFA14A Extra proxy material
Oct 2, 2026 ARS Annual report to shareholders Jun 30, 2026
Oct 2, 2026 DEFA14A Extra proxy material
Oct 2, 2026 DEF 14A Proxy statement Nov 11, 2026
Sep 23, 2026 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report Sep 18, 2026
Sep 8, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 6, 2026 10-K Annual report Jun 30, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 6, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 28, 2026 8-K items 5.02, 9.01 Officer or director change · Current report
Jun 1, 2026 11-K Employee plan annual report Dec 31, 2025
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 9.01 Results released · Current report
May 6, 2026 SCHEDULE 13G Large holder notice
Apr 29, 2026 SCHEDULE 13G Large holder notice
Apr 29, 2026 SCHEDULE 13G Large holder notice
Apr 9, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Apr 9, 2026 SCHEDULE 13G Large holder notice
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 3, 2026 8-K items 1.01, 1.02, 2.03, 9.01 Major agreement signed; Major agreement ended; New debt or obligation taken on · Current report Mar 2, 2026
Feb 24, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Feb 13, 2026 SCHEDULE 13G Large holder notice
Feb 6, 2026 8-K items 5.03, 7.01, 9.01 Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report Feb 5, 2026
Jan 28, 2026 10-Q Quarterly report Dec 31, 2025
Jan 28, 2026 8-K items 2.02, 9.01 Results released · Current report
Jan 21, 2026 SCHEDULE 13G/A Large holder update, amended
Dec 15, 2025 8-K items 8.01, 9.01 Other event · Current report
Nov 14, 2025 8-K item 5.07 Shareholder vote · Current report Nov 12, 2025
Oct 30, 2025 10-Q Quarterly report Sep 30, 2025
Oct 30, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 9, 2025 SCHEDULE 13G/A Large holder update, amended
Oct 7, 2025 8-K items 8.01, 9.01 Other event · Current report Oct 6, 2025
Oct 2, 2025 ARS Annual report to shareholders Jun 30, 2025
Oct 2, 2025 DEFA14A Extra proxy material
Oct 2, 2025 DEF 14A Proxy statement Nov 12, 2025
40 of 310 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CVSA · research, not advice